[go: up one dir, main page]

PL3866931T3 - Związki zawierające deuter - Google Patents

Związki zawierające deuter

Info

Publication number
PL3866931T3
PL3866931T3 PL19790194.5T PL19790194T PL3866931T3 PL 3866931 T3 PL3866931 T3 PL 3866931T3 PL 19790194 T PL19790194 T PL 19790194T PL 3866931 T3 PL3866931 T3 PL 3866931T3
Authority
PL
Poland
Prior art keywords
compounds containing
containing deuterium
deuterium
compounds
Prior art date
Application number
PL19790194.5T
Other languages
English (en)
Inventor
Fredrik Lehmann
Original Assignee
Oncopeptides Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1816998.7A external-priority patent/GB201816998D0/en
Priority claimed from GBGB1909695.7A external-priority patent/GB201909695D0/en
Application filed by Oncopeptides Ab filed Critical Oncopeptides Ab
Publication of PL3866931T3 publication Critical patent/PL3866931T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL19790194.5T 2018-10-18 2019-10-17 Związki zawierające deuter PL3866931T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1816998.7A GB201816998D0 (en) 2018-10-18 2018-10-18 Compounds
GBGB1909695.7A GB201909695D0 (en) 2019-07-05 2019-07-05 Compounds
PCT/EP2019/078250 WO2020079165A1 (en) 2018-10-18 2019-10-17 Compounds containing deuterium

Publications (1)

Publication Number Publication Date
PL3866931T3 true PL3866931T3 (pl) 2023-06-19

Family

ID=68290247

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19790194.5T PL3866931T3 (pl) 2018-10-18 2019-10-17 Związki zawierające deuter

Country Status (19)

Country Link
US (1) US12152087B2 (pl)
EP (1) EP3866931B1 (pl)
JP (2) JP7603199B2 (pl)
KR (1) KR20210078487A (pl)
CN (1) CN112930214A (pl)
AU (1) AU2019362389B2 (pl)
BR (1) BR112021007060A2 (pl)
CA (1) CA3116198A1 (pl)
DK (1) DK3866931T3 (pl)
ES (1) ES2942468T3 (pl)
FI (1) FI3866931T3 (pl)
HU (1) HUE061801T2 (pl)
IL (1) IL282231B1 (pl)
MA (1) MA53904A (pl)
MX (1) MX2021004474A (pl)
PL (1) PL3866931T3 (pl)
SG (1) SG11202103726RA (pl)
WO (1) WO2020079165A1 (pl)
ZA (1) ZA202102492B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201905477D0 (en) * 2019-04-17 2019-05-29 Oncopeptides Ab Novel formulations
EP4347615A1 (en) * 2021-06-01 2024-04-10 Synthon B.V. Process for making melflufen or a salt thereof
EP4366721A1 (en) 2021-07-08 2024-05-15 Oncopeptides Innovation AB Melflufen for use in the treatment of multiple myeloma
GB202109894D0 (en) 2021-07-08 2021-08-25 Oncopeptides Ab Novel treatments
GB202109896D0 (en) 2021-07-08 2021-08-25 Oncopeptides Ab Novel treatments
GB202109895D0 (en) 2021-07-08 2021-08-25 Oncopeptides Ab Novel treatments
GB202204171D0 (en) 2022-03-24 2022-05-11 Oncopeptides Ab Novel formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0002202D0 (sv) 2000-06-13 2000-06-13 Karolinska Innovations Ab New peptides
ES2652289T3 (es) 2008-09-18 2018-02-01 Auspex Pharmaceuticals, Inc. Derivados deuterados de benzoquinolina como inhibidores del transportador de monoamina vesicular 2
US20120003330A1 (en) 2010-06-01 2012-01-05 Auspex Pharmaceuticals, Inc. Benzoquinolone inhibitors of vmat2
HUE060783T2 (hu) * 2011-04-28 2023-04-28 Oncopeptides Ab Citotoxikus dipeptidek liofilizált készítménye
CN104684555A (zh) 2012-09-18 2015-06-03 奥斯拜客斯制药有限公司 囊泡单胺转运体2的氘化苯并喹啉抑制剂的制剂药代动力学
CN108685860B (zh) 2012-10-26 2022-04-05 肿瘤多肽股份公司 美法仑氟灭酰胺的冻干制剂
EA201500801A1 (ru) 2013-01-31 2016-01-29 Ауспекс Фармацетикалс, Инк. Бензохинолоновые ингибиторы vmat2
WO2014122184A1 (en) * 2013-02-05 2014-08-14 Cdrd Berolina Ab Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds
JP6542222B2 (ja) 2013-12-03 2019-07-10 オースペックス ファーマシューティカルズ インコーポレイテッド ベンゾキノリン化合物の製造方法
CN110229159B (zh) * 2013-12-18 2021-08-24 康塞特医药品有限公司 卢索替尼的氘代衍生物
IL305352A (en) 2015-03-06 2023-10-01 Auspex Pharmaceuticals Inc Methods for the treatment of abnormal involuntary movement disorders
GB201507903D0 (en) * 2015-05-08 2015-06-24 Oncopeptides Ab Process for preparation of nitrogen mustard derivatives
GB201521217D0 (en) * 2015-12-01 2016-01-13 Oncopeptides Ab Dosage regimens

Also Published As

Publication number Publication date
MX2021004474A (es) 2021-08-24
IL282231A (en) 2021-05-31
JP2022512736A (ja) 2022-02-07
DK3866931T3 (da) 2023-04-24
BR112021007060A2 (pt) 2021-07-20
CA3116198A1 (en) 2020-04-23
EP3866931B1 (en) 2023-02-15
HUE061801T2 (hu) 2023-08-28
AU2019362389A1 (en) 2021-06-03
FI3866931T3 (fi) 2023-05-10
EP3866931A1 (en) 2021-08-25
US20210388024A1 (en) 2021-12-16
JP7603199B2 (ja) 2024-12-20
MA53904A (fr) 2021-08-25
ES2942468T3 (es) 2023-06-01
ZA202102492B (en) 2024-04-24
KR20210078487A (ko) 2021-06-28
US12152087B2 (en) 2024-11-26
IL282231B1 (en) 2025-03-01
JP2024150488A (ja) 2024-10-23
CN112930214A (zh) 2021-06-08
SG11202103726RA (en) 2021-05-28
WO2020079165A1 (en) 2020-04-23
AU2019362389B2 (en) 2024-12-12

Similar Documents

Publication Publication Date Title
PL3866931T3 (pl) Związki zawierające deuter
DK3692040T3 (da) Kemiske forbindelser
LT3519420T (lt) Cikliniai dinukleotidų junginiai
DK3308860T3 (da) Patronanordning
EP3422112A4 (en) TONER CARTRIDGE
MA53566A (fr) Cartouche
EP3571551A4 (en) DEVELOPMENT CARTRIDGE
HUE048902T2 (hu) Új ROR gamma modulátor vegyületek
ES1162033Y (es) Mochila interactiva
EP3566532A4 (en) RANDOM ACCESS CONFIGURATIONS
SMT202200173T1 (it) Composti
PL3174794T5 (pl) Satelita zawierający instrument optyczny do fotografowania
DK3370804T3 (da) Patronbæreranordning
EP3768670A4 (en) IMIDAZOLIDIN-2-ONE COMPOUNDS AS PRMT5 MODULATORS
EP3617810A4 (en) DEVELOPMENT CARTRIDGE
EP3857311C0 (en) DEVELOPMENT CARTRIDGE
EP3447586A4 (en) DEVELOPING CARTRIDGE
EP3877996A4 (en) Dimethylammonium-containing perovskite devices
EP3836173A4 (en) REACTOR
EP3779601A4 (en) DEVELOPMENT CARTRIDGE
EP3438760A4 (en) DEVELOPER CARTRIDGE
EP3658993A4 (en) DEVELOPMENT CARTRIDGE
ITUB20161130A1 (it) Recipiente di contenimento di sostanze
EP3612182A4 (en) PATCH CONTAINING RUPATADINE
EP3406161A4 (en) MECHANISM